Mazdutide Research Peptide: A Potent Dual GLP-1/GCGR Agonist for Metabolic Studies
In advanced metabolic and obesity research, Mazdutide research peptide has emerged as a highly promising synthetic tool. This dual agonist targets both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). By activating these two complementary metabolic pathways, it provides a unique model for studying appetite suppression, energy expenditure, and comprehensive metabolic regulation. At Wuhan Top Miracle Peptides, we supply high‑purity Mazdutide research peptide to laboratories and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is synthesised using solid‑phase peptide synthesis, purified by preparative HPLC, and validated by mass spectrometry to meet the strictest research standards.
What Is Mazdutide and How Does It Work?
Mazdutide research peptide (also known as IBI‑362 or LY‑3305677) is a long‑acting synthetic analogue of the endogenous gut hormone oxyntomodulin. It is engineered to activate two distinct receptor pathways, each contributing uniquely to the overall metabolic profile:
-
GLP‑1R activation: Primarily responsible for glucose‑dependent insulin secretion, appetite suppression, and delayed gastric emptying.
-
GCGR activation: Promotes energy expenditure via increased fatty acid oxidation and thermogenesis, complementing the effects of GLP‑1R agonism.
The peptide is notably more potent at GLP‑1R, with a receptor binding ratio of approximately 5:1, ensuring that the well‑tolerated GLP‑1 effects predominate while the GCGR component adds a distinct metabolic boost. In preclinical models, Mazdutide research peptide has been shown to bind human GCGR with a Ki of 17.7 nM and GLP‑1R with a Ki of 28.6 nM, confirming its high‑affinity dual agonist profile.
Key Research Applications
Mazdutide research peptide has been investigated across several metabolic and physiological domains. The table below summarises the primary areas of research and key findings.
| Research Area | Key Observations |
|---|---|
| Obesity & Body Weight Regulation | Significant dose‑dependent weight loss; Phase 3 trials report mean reductions of up to 14% in body weight. A 12‑week study in diabetic mice demonstrated that Mazdutide (15 nmol/kg, subcutaneous single dose) markedly reduced body weight and food intake. |
| Type 2 Diabetes (T2D) Research | In a Phase 3 trial, Mazdutide (6 mg) reduced HbA1c by 2.15% versus placebo (‑0.14%) at week 24. A 2025 study highlighted its dual‑receptor mechanism in reducing hyperglycaemia. |
| Hepatic Lipid Metabolism (MASLD/NAFLD) | A 2026 Phase 2 trial in MASLD patients showed that Mazdutide reduced liver fat content by up to 68.8% after 32 weeks. Over 60% of participants receiving 10 mg or 16 mg achieved complete steatosis resolution. |
| Uric Acid / Hyperuricemia | Mazdutide significantly lowers serum uric acid levels in hyperuricemic rats by enhancing fatty acid oxidation and regulating energy metabolism, thereby reducing purine precursors. |
| Cognitive Function | In a 2025 multi‑omics study, Mazdutide significantly improved cognitive performance in a T2D mouse model compared to dulaglutide, a GLP‑1R agonist. Multi‑omics revealed distinct neuroprotective pathways involving energy metabolism and synaptic plasticity. |
Chemical & Physical Specifications
Understanding the molecular characteristics of Mazdutide research peptide is essential for reproducible experimental design. Below are the verified specifications.
| Parameter | Specification |
|---|---|
| Amino Acid Sequence | His‑{Aib}‑Gln‑Gly‑Thr‑Phe‑Thr‑Ser‑Asp‑Tyr‑Ser‑Lys‑Tyr‑Leu‑Asp‑Glu‑Lys‑Lys‑Ala‑Lys‑{AEEA‑AEEA‑γGlu‑Nonadecanoic acid}‑Glu‑Phe‑Val‑Glu‑Trp‑Leu‑Leu‑Glu‑Gly‑Gly‑Pro‑Ser‑Ser‑Gly‑NH₂ |
| Molecular Formula | C₂₁₀H₃₂₂N₄₆O₆₇ |
| Molecular Weight | 4563.06 g/mol |
| CAS Number | 2259884‑03‑0 |
| Purity (HPLC) | ≥99% (batch‑dependent) |
| Appearance | White to off‑white lyophilised powder |
Reconstitution & Handling Protocol
As a lyophilised product, Mazdutide research peptide must be reconstituted correctly to preserve its structural and functional integrity.
-
Preparation: Bring the sealed Mazdutide vial and your chosen diluent (sterile bacteriostatic water or sterile PBS) to room temperature. Failing to do so can cause condensation on the lyophilised powder, reducing stability.
-
Sanitisation: Wipe the rubber stoppers of both the Mazdutide vial and the diluent vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely.
-
Reconstitution: Draw the required volume of diluent into a sterile syringe (e.g., 1 mL to dissolve 5 mg of peptide yields a 5 mg/mL concentration). Inject the diluent slowly against the inner glass wall. Do not spray directly onto the powder.
-
Dissolution: Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as this can cause denaturation.
-
Aliquoting & Storage: Immediately aliquot the reconstituted peptide into single‑use sterile vials and store at –20°C.
Safety Disclaimer: Due to the potent biological activity of Mazdutide research peptide, all handling must be performed in a designated biological safety cabinet using appropriate personal protective equipment (gloves, lab coat, eye protection).
Storage & Stability
| Storage Condition | Shelf Life | Notes |
|---|---|---|
| Lyophilised, –20°C, unopened | 2 years | Protected from light, desiccant recommended |
| Lyophilised, 2–8°C, unopened | 12 months | –20°C storage preferred for long‑term stability |
| Reconstituted, 2–8°C | Up to 28 days | Use aseptic technique |
| Reconstituted, –20°C (aliquots) | 6 months | Single‑use aliquots only; avoid repeated freeze‑thaw |
All reconstituted solutions should be stored in tightly sealed vials and used within 1 month if kept under refrigeration.
Frequently Asked Questions
Q1: What is Mazdutide?
Mazdutide research peptide is a synthetic, long‑acting dual agonist of the GLP‑1 receptor (GLP‑1R) and the glucagon receptor (GCGR), derived from the gut hormone oxyntomodulin. It is a 34‑amino acid peptide with a fatty‑acid side chain that extends its half‑life.
Q2: How does Mazdutide differ from other dual agonists like tirzepatide?
While tirzepatide activates GLP‑1R and the glucose‑dependent insulinotropic polypeptide receptor (GIPR), Mazdutide targets GLP‑1R and GCGR. The GCGR component promotes energy expenditure and fatty acid oxidation, which may offer distinct advantages in metabolic research models.
Q3: Is Mazdutide legal to purchase in the UK for research?
Yes. Mazdutide research peptide is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the UK for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims.
Q4: What purity level does your Mazdutide meet?
Our Mazdutide research peptide is tested to ≥99% purity by HPLC. Each batch is accompanied by a Certificate of Analysis (COA) that includes chromatographic data and mass spectrometry confirmation.
Q5: What solvent should I use for reconstitution?
Sterile bacteriostatic water or sterile PBS (pH 5–7) is recommended. The peptide is highly soluble in ultrapure water.
Q6: What is the primary mechanism of action for Mazdutide?
Mazdutide activates both GLP‑1R and GCGR, leading to reduced appetite, increased insulin secretion, enhanced energy expenditure, and improved lipid metabolism via fatty acid oxidation pathways.
Q7: Are there any safety concerns associated with Mazdutide research?
In clinical studies, the most common adverse events were mild‑to‑moderate gastrointestinal effects (e.g., nausea, diarrhoea), consistent with the GLP‑1 class. For laboratory use, standard peptide handling precautions apply.
Why Choose Wuhan Top Miracle Peptides for Your Research Needs?
Your research requires materials that you can trust. We supply Mazdutide research peptide and a comprehensive range of research peptides under strict quality assurance protocols, fully aligned with Google’s E‑E‑A‑T principles (Experience, Expertise, Authoritativeness, Trustworthiness).
-
Verified Purity: Independent HPLC analysis with purity guaranteed ≥99% for every batch.
-
GMP‑Compliant Manufacturing: All peptides are synthesised in ISO 13485:2016 and GMP‑certified facilities, ensuring batch‑to‑batch consistency.
-
Comprehensive Documentation: Batch‑specific Certificates of Analysis (COA) are available for every order.
-
Wholesale Supply: We serve research institutions and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.
-
UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only.
Researchers across the United Kingdom, including those at leading institutions in London, Cambridge, and Edinburgh, trust us for fast domestic delivery, transparent documentation, and professional support.
Bulk Peptides Page
Shipping & Returns Page
Contact Page
Quality / Compliance Page
Google Search Central
MHRA medicine advertising guidance
ASA/CAP medicine and health product advertising rules
Scientific reference source for Mazdutide
Documentation, COA, and Quality Information
Professional buyers may request available documentation before discussing supply. This section should link directly to your COA page.
Quality Message
At Wuhan Top Miracle Peptides, verified buyers may contact our team to request available documentation, batch information, COA details, purity-related information, storage notes, and supply requirements for Mazdutide. Documentation availability may vary by product, batch, country, and buyer qualification.
- COA request process
- Batch or lot information where available
- Product label verification
- Storage and handling notes where legally appropriate
- Buyer verification requirements
- Business contact details
- Professional-only disclaimer
- Shipping eligibility notice
Professional Supply Regions
Wuhan Top Miracle Peptides supports wholesale and professional product enquiries across multiple regions.
Enquiry Regions
- United Kingdom
- France
- Germany
- Spain
- Sweden
- Italy
- USA
- Wider Europe
From obesity and type 2 diabetes to hepatic steatosis, hyperuricemia, and cognitive function, Mazdutide research peptide offers a versatile, well‑characterised dual agonist tool for advanced metabolic research. Its unique GLP‑1R/GCGR activation profile provides a distinct advantage over single‑agonist compounds, enabling studies on appetite, energy balance, and lipid metabolism within a single molecular platform. By choosing high‑purity, lab‑verified Mazdutide from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.
Ready to advance your metabolic research with Mazdutide? Explore our product catalogue, request a wholesale quote, or contact our support team today to discuss your specific laboratory needs. Place your order now and receive lab‑tested, GMP‑quality peptides delivered directly to your facility in the UK, EU, or USA.




Reviews
There are no reviews yet.